Search for: All records

Understanding the preferences for new and future transportation technologies is important to ensure an efficient and equitable future transportation system. A survey was conducted of Americans’ preferences for several such technologies. Americans are concerned about vehicle range and charging station availability for electric vehicles (EVs) and hesitant about autonomous vehicle (AV) safety. Opinions about many transportation technologies, such as vertical takeoff and landing (i.e., air taxis), shared parking, and air-drone delivery are mixed. These less familiar technologies require continued tracking of preferences. A 55% increase is estimated in the probability of an individual choosing a battery electric vehicle (BEV) pickup truck if its fuel economy increases by about 9%. This result supports a market for BEV pickup trucks currently under development by many automakers. The preference for vehicle autonomation appears to depend on the use case. Driving task automation is preferred by residents of low-density, car-dependent areas where long commutes are common. In contrast, automated parking technologies are favored by those living in denser communities. Intermittent bus lanes are favored by those living in high population density areas, but not among those in areas with high shares of zero-vehicle households. These results provide indications of where to direct future research in the field.

 

Remote monitoring and evaluation of pulmonary diseases via telemedicine are important to disease diagnosis and management, but current telemedicine solutions have limited capability of objectively examining the airway's internal physiological conditions that are crucial to pulmonary disease evaluation. Existing solutions based on smartphone sensing are also limited to externally monitoring breath rates, respiratory events, or lung function. In this paper, we present PTEase, a new system design that addresses these limitations and uses commodity smartphones to examine the airway's internal physiological conditions. PTEase uses active acoustic sensing to measure the internal changes of lower airway caliber, and then leverages machine learning to analyze the sensory data for pulmonary disease evaluation. We implemented PTEase as a smartphone app, and verified its measurement error in lab-controlled settings as <10%. Clinical studies further showed that PTEase reaches 75% accuracy on disease prediction and 11%-15% errors in estimating lung function indices. Given that such accuracy is comparable with that in clinical practice using spirometry, PTEase can be reliably used as an assistive telemedicine tool for disease evaluation and monitoring. 

Algal cultivations are strongly influenced by light and dark cycles. In this study, genome-scale metabolic models were applied to optimize nutrient supply during alternating light and dark cycles ofChlorella vulgaris. This approach lowered the glucose requirement by 75% and nitrate requirement by 23%, respectively, while maintaining high final biomass densities that were more than 80% of glucose-fed heterotrophic culture. Furthermore, by strictly controlling glucose feeding during the alternating cycles based on model-input, yields of biomass, lutein, and fatty acids per gram of glucose were more than threefold higher with cycling compared to heterotrophic cultivation. Next, the model was incorporated into open-loop and closed-loop control systems and compared with traditional fed-batch systems. Closed-loop systems which incorporated a feed-optimizing algorithm increased biomass yield on glucose more than twofold compared to standard fed-batch cultures for cycling cultures. Finally, the performance was compared to conventional proportional-integral-derivative (PID) controllers. Both simulation and experimental results exhibited superior performance for genome-scale model process control (GMPC) compared to traditional PID systems, reducing the overall measured value and setpoint error by 80% over 8 h. Overall, this approach provides researchers with the capability to enhance nutrient utilization and productivity of cell factories systematically by combining genome-scale models and controllers into an integrated platform with superior performance to conventional fed-batch and PID methodologies.

 

Pulmonary diseases, such as asthma and Chronic Obstructive Pulmonary Disease (COPD), constitute a major public health challenge. The disease symptoms, including airway obstruction and inflammation, usually result in changes in airway mechanical properties, such as the caliber and impedance of the airway. To measure such airway properties for disease evaluation and diagnosis purposes, pulmonary function tests (PFT) has been widely adopted. However, most existing PFT systems require expensive and cumbersome hardware that are impossible to be used out of clinic. To allow out-clinic continuous pulmonary disease evaluation, in this paper we present AWARE, a new sensing and AI system that supports accurate and reliable PFT using commodity smartphones. AWARE uses a smartphone to transmit acoustic signals and reconstructs the profile of human airway based on the analysis of reflected acoustic waves captured from the smartphone's microphone. The subject's pulmonary condition is then evaluated by a multi-task learning model that integrates both the airway measurements and the subject's lung function records as the ground truth. Evaluations on 75 human subjects demonstrate that AWARE has the capability to achieve 80% accuracy on distinguishing between humans with healthy pulmonary function and with asthma symptoms.